Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 29 | 27↓4.4% | 27↓2.8% | 60↑125.7% | 434↑624.1% |
| Gross Profit | 29 | 27↓4.4% | 27↓2.8% | 60↑125.7% | 434↑624.1% |
| Operating Income | -65 | -126↓95.1% | -131↓4.4% | -94↑28.7% | 253↑370.0% |
| Net Income | -66 | -126↓89.8% | -127↓1.5% | -79↑38.0% | 275↑448.5% |
| EBITDA | -64 | -123↓93.6% | -128↓4.0% | -90↑29.4% | 254↑380.8% |
| EPS Diluted | -1.92 | -2.65↓38.0% | -2.52↑4.9% | -1.39↑44.8% | 4.23↑404.3% |